Qomel Co (SAU:9600) Revenue: ﷼138.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9600 Qomel Co SAU:9600
20 GF Score
Price ﷼43.00
! 3 Warning Signs
View Full Analysis

What is Qomel Co Revenue?

Qomel Co SAU:9600 -0.05% 20 Revenue is ﷼138.0 Mil as of Jun. 2026. GuruFocus rates SAU:9600 with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Qomel Co's revenue for the six months ended in Jun. 2026 was ﷼71.2 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼138.0 Mil. Qomel Co's Revenue per Share for the six months ended in Jun. 2026 was ﷼10.16. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼19.70.

During the past 12 months, the average Revenue per Share Growth Rate of Qomel Co was 5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Qomel Co  (SAU:9600) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Qomel Co Revenue Related Terms

Qomel Co Revenue Historical Data

* Premium members only.

The historical data trend for Qomel Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qomel Co Revenue Chart

Qomel Co Annual Data
Trend Dec23 Dec24 Dec25
Revenue
105.47 124.20 132.23

Qomel Co Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Revenue Get a 7-Day Free Trial 58.56 65.64 65.49 66.74 71.24

Qomel Co Revenue Competitor Comparison

For the Pharmaceutical Retailers subindustry, Qomel Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qomel Co Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Qomel Co's Revenue distribution charts can be found below:

* The bar in red indicates where Qomel Co's Revenue falls into.


SAU:9600
20GF Score
Qomel Co SAU:9600
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qomel Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ﷼138.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of ﷼138.0 Mil mean?
Qomel Co (SAU:9600) has a Revenue of ﷼138.0 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Qomel Co and its competitors.
Is Qomel Co's Revenue too high?
Qomel Co's current Revenue is ﷼138.0 Mil. Overall, Qomel Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Qomel Co's Revenue compare to competitors?
Qomel Co's Revenue of ﷼138.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Qomel Co and its competitors. Qomel Co's current Revenue is ﷼138.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qomel Co stock overvalued right now?
Qomel Co (SAU:9600) has a current Revenue of ﷼138.0 Mil. The current Revenue is ﷼138.0 Mil. Qomel Co's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Qomel Co (SAU:9600), the current Revenue is ﷼138.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Qomel Co Business Description

Address 3221 Prince Mamdouh bin Abdul Aziz Street, Sulaymaniyah District, Riyadh, SAU
Qomel Co is a Saudi Arabian-based healthcare company that provides high-quality medicines and innovative medical services whose core business focuses on institutional and government supply through a professional field force and an in-depth knowledge of the local business environment They offer services such as pharmaceutical and medical supplies.
20GF Score

Get the complete analysis for SAU:9600

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼43.00
Price